Absolute Antibody

United Kingdom Founded: 2012 • Age: 14 yrs Acquired By LSBio
Engineered antibodies are produced for research and diagnostics applications.

About Absolute Antibody

Absolute Antibody is a company based in United Kingdom founded in 2012 was acquired by LSBio in December 2020. Absolute Antibody has raised $1.4 million across 2 funding rounds from investors including LSBio, Eureka Network and Innovate UK. The company has 43 employees. Absolute Antibody operates in a competitive market with competitors including KBI Biopharma, Aldevron, Kemwell Biopharma, Eurogentec and Ovagen, among others.

  • Headquarter United Kingdom
  • Employees 43
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website absoluteantibody.com
  • Social LinkedIn X
  • Acquired by LSBio (Dec 2020)
  • Legal Name Absolute Antibody Limited
  • Date of Incorporation 02 Aug, 2012
  • Jurisdiction REDCAR, CLEVELAND, ENGLAND
Key Metrics
  • Total Equity Funding
    $1.4M (USD)

    in 2 rounds

  • Investors
    LSBio

    & 2 more

  • Employee Count
    43
  • Acquired by
    LSBio

    (Dec 2020)

Funding Insights of Absolute Antibody

Absolute Antibody has successfully raised a total of $1.4M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $1.4M
  • Total Rounds 2
  • First Round $1.4M

    (Apr 2014)

  • Investors Count 2

All 2 funding rounds of Absolute Antibody with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Dec 2020–Grant––
Apr 2014$1.4MSeed–Innovate UK
–
Valuation history

3 investors in total: 3 institutional.

Investors in Absolute Antibody

Absolute Antibody has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include LSBio, Eureka Network and Innovate UK.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Business management consulting services are offered to clients.
1985eurekanetwork.orgBrussels, Belgium
-
–innovateuk.gov.uk-
Reagents and kits for immunology research are developed and manufactured.
1995lsbio.comSeattle, United States
Premium access

Investor details for Absolute Antibody

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Absolute Antibody

10 people are tracked at Absolute Antibody (1 in leadership, 1 in board & advisors, 8 in team); the tracked headcount is 43.

NameRoleGroup
Michael Fiebig
Chief Scientific OfficerLeadership
Nicholas Hutchings
AdvisorBoard & advisors
MILI KHATARKAR
Scientist I R&dTeam
Rachel Gibson
Scientist - Upstream SupervisorTeam
Adriana Correa
Business Development ManagerTeam
Alex Scott
Business Development Manager UK And EUTeam
Kathrin Günther
Business Development Manager EuropeTeam
Cameron Barker
Scientist IITeam
Daniel S.
ScientistTeam
Sarah Teaz
Scientist IITeam
Premium access

Complete people profiles for Absolute Antibody

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Absolute Antibody

4 dated milestones of Absolute Antibody across 8 years, from founding to its latest funding, stage changes and deals.

  1. Founded Absolute Antibody is founded.
  2. Funding First funding round of $1.4M.
  3. Funding Latest funding round, Grant,.
  4. Exit Acquired by LSBio.

Competitors of Absolute Antibody

Absolute Antibody operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as KBI Biopharma, Aldevron, Kemwell Biopharma, Eurogentec and Ovagen, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
kbibiopharma.com1996Durham, United States$18.29M1,243
Provider of protein formulation, process & cell line development, and cGMP services
aldevron.com1998Fargo, United States–747
Developer and custom manufacturer of nucleic acids, proteins and antibodies for research, clinical and commercial applications
kemwellbiopharma.com1980Bengaluru, India$5.72M298
Integrated biologics development and manufacturing are provided as a CDMO.
eurogentec.com1985Seraing, Belgium–426
Oligonucleotides, peptides, and antibodies are developed and manufactured by Eurogentec.
ovagen.ie2000Mayo, Ireland$25.21M–
Provider of germ-free and specific pathogen free production of eggs for vaccine and antibody manufacturing services
laurus.bio2005Bengaluru, India$18.89M6,094
Precision fermentation services for biopharma and food are provided.
idt-biologika.com1921Dessau Rosslau, Germany––
Vaccines and biologics are developed and manufactured by IDT Biologika.
eirgenix.com2012Taipei, Taiwan$90.58M–
Biologics development and manufacturing services are offered by EirGenix.
omniabio.com2001Rockville, United States$25.4M–
Process development and manufacturing services for biologics are provided.
Premium access

Detailed competitors of Absolute Antibody

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Absolute Antibody

The website of Absolute Antibody (absoluteantibody.com) receives about 34.2K visits a month.

  • Monthly visits
    34.2K

    ▲ 9.8% vs previous month

Similar websites

Websites whose visitors overlap most with Absolute Antibody. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
abcepta.com
100%
–#2,238,406View details
huabio.com
huabio.com
98%
–#2,115,449–
usbio.net
98%
50K#662,701View details
affbiotech.com
affbiotech.com
96%
–#1,549,129–
creativebiolabs.net
creativebiolabs.net
94%
–#1,184,982–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 40 similar websites and full traffic analytics for Absolute Antibody

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 40 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Latest news on Absolute Antibody

Premium access

Complete news archive for Absolute Antibody

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to Absolute Antibody

10 companies that operate in the same segment as Absolute Antibody (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Developer of integrated contract research development and manufacturing services
2007Bengaluru, Karnataka, IndiaUSD 35.74 MUSD 226.38 M1,820
Drug discovery and development services are provided to biopharma sector.
1993Hamburg, Hamburg, GermanyUSD 25 MUSD 926.33 M4,830
Drug discovery and development services for small molecules are provided.
2003Beijing, ChinaUSD 320 M–476
Suite solutions are provided for payers and healthcare providers.
1998Princeton, New Jersey, United StatesUSD 255.15 MUSD 374.1 M4,490
Wearable insulin infusion systems are developed for diabetes patients.
2000Boston, Massachusetts, United StatesUSD 120.4 MUSD 2.71 B3,900
Developer of small-molecule drugs
1991Los Angeles, California, United StatesUSD 50 MUSD 348.97 M407
Pharmaceutical and biotechnology company
2005Hyderabad, Telangana, IndiaUSD 229.73 MUSD 726.15 M12,470
Pharmaceutical products for treating multiple diseases are provided.
1849New York, New York, United StatesUSD 8 MUSD 266.99 M1,770
Provider of laboratory tests for physicians
1969Burlington, Vermont, United States–USD 13.95 B70,000
India's leading healthcare products distribution platform
2018Mumbai, Maharashtra, IndiaUSD 59.67 MUSD 702.49 M4,260
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Absolute Antibody

Absolute Antibody was founded in 2012 and raised its 1st funding round 2 years after it was founded.

Absolute Antibody is headquartered in United Kingdom.

Absolute Antibody is a funded company, having raised a total of $1.4M across 2 funding rounds to date. The company's 1st funding round was a Seed of $1.4M, raised on Apr 2014.

Absolute Antibody has 43 employees.

Absolute Antibody was founded in 2012 in the United Kingdom, focusing on the biotechnology sector. Antibodies are engineered for preclinical research and diagnostics through a proprietary platform utilizing transient transfection for production at milligram to gram scales. Services provided include antibody sequencing, manufacturing, and engineering, with support extended to preclinical studies via batch production methods. Operations center on sequenced and modified antibody formats known as AbsoluteAbs.

Absolute Antibody's top competitors include KBI Biopharma, Aldevron and Ovagen.

Absolute Antibody has 3 investors. Key investors include LSBio, Eureka Network, and Innovate UK.

Absolute Antibody operates through Absolute Antibody Limited.

Yes. Absolute Antibody was acquired by LSBio in December 2020.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available